88 results
Page 2 of 5
8-K
EX-99.1
3mvqukk uvtj4xat
1 Jun 21
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
7:09am
DEFA14A
4j6 nws3wb05e8k
3 Apr 20
Additional proxy soliciting materials
5:17pm
8-K
EX-2.1
dpolciqprr3 2n
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-99.2
4cjv9qdxi4ixolvsvd
25 Apr 19
Alkermes Plc Reports First Quarter 2019 Financial Results
7:05am